推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 2017年，北京市將啟動中醫(yī)服務(wù)項(xiàng)目價(jià)格動態(tài)監(jiān)控平臺?！笆濉逼陂g，還將研究發(fā)布北京市中藥飲片指導(dǎo)價(jià)格。與此同時(shí)，北京市的三級中醫(yī)醫(yī)療機(jī)構(gòu)將達(dá)到30家。
2月24日，記者從2017年北京中醫(yī)藥工作會議獲悉，2017年，北京市將研究制定系列中醫(yī)藥控費(fèi)和規(guī)范行為的措施，將利用大數(shù)據(jù)加強(qiáng)中藥材生產(chǎn)流通全過程管理和質(zhì)量追溯，以及價(jià)格動態(tài)監(jiān)測分析和預(yù)測預(yù)警。完善中藥不良反應(yīng)監(jiān)測制度。同時(shí)，研究發(fā)布北京市中藥飲片指導(dǎo)價(jià)格。記者了解到，對于中藥材本市目前是由市場自主定價(jià)，如果出臺政府指導(dǎo)價(jià)，將使得其價(jià)格更加趨于合理和規(guī)范。
此外，根據(jù)規(guī)劃，“十三五”期間，北京市的三級中醫(yī)醫(yī)療機(jī)構(gòu)將達(dá)到30家，同時(shí)本市還將建設(shè)16個(gè)區(qū)域中醫(yī)醫(yī)療中心。還將建立5到10個(gè)不同種類的京津冀中醫(yī)醫(yī)聯(lián)體，建成50個(gè)中醫(yī)藥重點(diǎn)專科病區(qū)，年服務(wù)量達(dá)到200萬人。與此同時(shí)，探索建立1至2所提供遠(yuǎn)程醫(yī)療網(wǎng)絡(luò)服務(wù)的中醫(yī)類醫(yī)院。開展中醫(yī)藥文化進(jìn)校園項(xiàng)目，爭取把中醫(yī)藥納入北京市中小學(xué)校本課程。
